Zimmer Biomet Holdings (ZBH) stock had a bullish inflow of $29.79 million worth of trades on uptick and an outflow of $25.94 million in downticks on Tuesday. The total uptick to downtick ratio stood at 1.15. The net money flow into the stock was $3.85 million. The money flow data, which is calculated as the dollar value of composite uptick minus the downtick trades indicated bullish. The block trades had a total money flow of $1.93 million. An inflow of $1.46 million block trade was recorded on downticks. $3.4 million of block trade during Uptick was observed, which shows continued buying by the smart money on every weakness. The total uptick to downtick ratio of block trades was 2.32 in favor of the bulls. However, Zimmer Biomet Holdings (ZBH) stock traded down $0.74 , and reached $129.85, a drop of -0.57% over the previous day. On a weekly basis, the stock is 0.26%, over the previous weeks close.
Also, Barclays maintains their rating on the shares of Zimmer Biomet Holdings (NYSE:ZBH). The current rating of the shares is Overweight. Equity Analysts at the Firm raises the price target to $145 per share from $140 per share. The rating by the firm was issued on August 23, 2016.
Shares of Zimmer Biomet Holdings, Inc. appreciated by 0.08% during the last five trading days but lost 0.91% on a 4-week basis. Zimmer Biomet Holdings, Inc. is up 6.54% in the last 3-month period. Year-to-Date the stock performance stands at 27.14%.
Zimmer Biomet Holdings (NYSE:ZBH): The stock opened at $131.26 on Tuesday but the bulls could not build on the opening and the stock topped out at $131.32 for the day. The stock traded down to $128.85 during the day, due to lack of any buying support eventually closed down at $129.87 with a loss of -0.55% for the day. The stock had closed at $130.59 on the previous day. The total traded volume was 1,093,231 shares.
In a related news, The Securities and Exchange Commission has divulged that Collins Tony W., officer (VP, Controller and CAO) of Zimmer Biomet Holdings, Inc., had unloaded 1,287 shares at an average price of $129.29 in a transaction dated on August 12, 2016. The total value of the transaction was worth $166,396.
Zimmer Biomet Holdings, Inc., formerly Zimmer Holdings, Inc. is a musculoskeletal healthcare company. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company manages its operations through three geographic segments: the Americas, comprising principally of the United States and includes other North, Central and South American markets; Europe, comprising principally of Europe and includes the Middle East and African markets; and Asia Pacific, comprising primarily of Japan and includes other Asian and Pacific markets. The Company markets and sells products through three channels: direct to healthcare institutions, such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers, and directly to dental practices and dental laboratories.